Condition: Small Cell Lung Cancer (SCLC) · Colorectal Carcinoma (CRC) · Gastric Cancer (GC) · Sponsor: Thena Biotech S.r.l.
Single-centre, open-label, dose escalation phase I clinical trial, designed to evaluate mainly the safety and tolerability of the antitumor drug THE-0504 in patients with different types of solid tumors.
This description comes directly from the study's public registry record.
Pierpaolo Ceci, PhD · +39 0773822658 · pierpaolo.ceci@thenabiotech.com
Gennaro Daniele, PhD · +39 0630157300 · gennaro.daniele@policlinicogemelli.it
Always discuss trial participation with your own doctor first.
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Rome, Lazio, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07646106